NK cells regulate CD8+ T cell effector function in response to an intracellular pathogen. 2004

Ramakrishna Vankayalapati, and Peter Klucar, and Benjamin Wizel, and Stephen E Weis, and Buka Samten, and Hassan Safi, and Homayoun Shams, and Peter F Barnes
Center for Pulmonary and Infectious Disease Control, University of Texas Health Center, 11937 US Highway 271, Tyler, TX 75708, USA.

We studied the role of NK cells in regulating human CD8+ T cell effector function against mononuclear phagocytes infected with the intracellular pathogen Mycobacterium tuberculosis. Depletion of NK cells from PBMC of healthy tuberculin reactors reduced the frequency of M. tuberculosis-responsive CD8+IFN-gamma+ cells and decreased their capacity to lyse M. tuberculosis-infected monocytes. The frequency of CD8+ IFN-gamma+ cells was restored by soluble factors produced by activated NK cells and was dependent on IFN-gamma, IL-15, and IL-18. M. tuberculosis-activated NK cells produced IFN-gamma, activated NK cells stimulated infected monocytes to produce IL-15 and IL-18, and production of IL-15 and IL-18 were inhibited by anti-IFN-gamma. These findings suggest that NK cells maintain the frequency of M. tuberculosis-responsive CD8+IFN-gamma+ T cells by producing IFN-gamma, which elicits secretion of IL-15 and IL-18 by monocytes. These monokines in turn favor expansion of Tc1 CD8+ T cells. The capacity of NK cells to prime CD8+ T cells to lyse M. tuberculosis-infected target cells required cell-cell contact between NK cells and infected monocytes and depended on interactions between the CD40 ligand on NK cells and CD40 on infected monocytes. NK cells link the innate and the adaptive immune responses by optimizing the capacity of CD8+ T cells to produce IFN-gamma and to lyse infected cells, functions that are critical for protective immunity against M. tuberculosis and other intracellular pathogens.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007424 Intracellular Fluid The fluid inside CELLS. Fluid, Intracellular,Fluids, Intracellular,Intracellular Fluids
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Ramakrishna Vankayalapati, and Peter Klucar, and Benjamin Wizel, and Stephen E Weis, and Buka Samten, and Hassan Safi, and Homayoun Shams, and Peter F Barnes
January 2020, Frontiers in cellular and infection microbiology,
Ramakrishna Vankayalapati, and Peter Klucar, and Benjamin Wizel, and Stephen E Weis, and Buka Samten, and Hassan Safi, and Homayoun Shams, and Peter F Barnes
February 2008, Journal of immunology (Baltimore, Md. : 1950),
Ramakrishna Vankayalapati, and Peter Klucar, and Benjamin Wizel, and Stephen E Weis, and Buka Samten, and Hassan Safi, and Homayoun Shams, and Peter F Barnes
January 2012, Nature immunology,
Ramakrishna Vankayalapati, and Peter Klucar, and Benjamin Wizel, and Stephen E Weis, and Buka Samten, and Hassan Safi, and Homayoun Shams, and Peter F Barnes
June 2012, The Journal of allergy and clinical immunology,
Ramakrishna Vankayalapati, and Peter Klucar, and Benjamin Wizel, and Stephen E Weis, and Buka Samten, and Hassan Safi, and Homayoun Shams, and Peter F Barnes
August 2001, Current opinion in immunology,
Ramakrishna Vankayalapati, and Peter Klucar, and Benjamin Wizel, and Stephen E Weis, and Buka Samten, and Hassan Safi, and Homayoun Shams, and Peter F Barnes
September 1997, The Journal of experimental medicine,
Ramakrishna Vankayalapati, and Peter Klucar, and Benjamin Wizel, and Stephen E Weis, and Buka Samten, and Hassan Safi, and Homayoun Shams, and Peter F Barnes
October 2013, Journal of immunology (Baltimore, Md. : 1950),
Ramakrishna Vankayalapati, and Peter Klucar, and Benjamin Wizel, and Stephen E Weis, and Buka Samten, and Hassan Safi, and Homayoun Shams, and Peter F Barnes
August 2011, Nature reviews. Immunology,
Ramakrishna Vankayalapati, and Peter Klucar, and Benjamin Wizel, and Stephen E Weis, and Buka Samten, and Hassan Safi, and Homayoun Shams, and Peter F Barnes
November 2008, Free radical biology & medicine,
Ramakrishna Vankayalapati, and Peter Klucar, and Benjamin Wizel, and Stephen E Weis, and Buka Samten, and Hassan Safi, and Homayoun Shams, and Peter F Barnes
March 2009, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!